Anthocyanins (160 mg/day for 12 weeks) were shown to decrease pro-inflammatory cytokines, including caspase-1, IL-1β, and IL-18, in NAFLD patients [79]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.